Pharma Pulse 7/25/24: Driving CAR-Ts for Treatment in Cancer and Immunology, CrowdStrike Explains What Went Wrong in Global Outage & more

Driving CAR-Ts for Treatment in Cancer and Immunology

A deep dive into why this therapy has demonstrated effectiveness in various areas, including for tumors.

Ongoing Stigma Remains a Major Obstacle in the Fight Against HIV | AIDS 2024

At the 25th annual international AIDS Conference in Munich, Germany, a group of international experts discussed the impact of HIV-related stigma and discrimination on efforts to end the HIV pandemic as a public health threat by 2030.

CrowdStrike Explains What Went Wrong Days After Global Tech Outage

Cybersecurity company lays out steps to prevent future quality-control disruptions.

Pfizer Announces Positive Topline Results From Phase III Study of Hemophilia A Gene Therapy Candidate

Giroctocogene fitelparvovec study meets primary and key secondary objectives of superiority compared to prophylaxis.

Matt Braun on LinkedIn

Great insights by Abid Rahman from EVERSANA on the power of #AIas it revolutionizes operations across many industries, including #pharma. Always great to see a publication like Pharmaceutical Executive want to connect with experts.

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs